“Importantly, all of the group’s operating assets remain profitable, with the loss driven primarily by high interest costs stemming from elevated gearing levels,” the group says.
Thomson Medical Group (TMG) has reported a net loss of $47 million for the FY2025 ended June 30, largely attributable to a one-off, non-cash goodwill impairment and continued strategic investments.
This refers to the fair values of assets acquired and liabilities assumed during the acquisition of Far East Medical Vietnam Limited (FEMVN) which took place in 2023. As the purchase price allocation for the acquisition was incomplete as at June 30, 2024, a resultant goodwill of $406.4 million was accounted for which was paid off in this financial year.
